Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban
Crossref DOI link: https://doi.org/10.1186/s12872-017-0607-1
Published Online: 2017-06-29
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tsyganov, A. http://orcid.org/0000-0002-6667-0539
Shapieva, A.
Sandrikov, V.
Fedulova, S.
Mironovich, S.
Dzeranova, A.
Lyan, E.